The Journal of Pediatrics
Volume 156, Issue 3 , Pages 350-351 , March 2010

Treatment Adherence in Patients with Sickle Cell Anemia

  • Dennis Drotar, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Dennis Drotar, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7039, Cincinnati, OH 45229-3039.

References 

  1. Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood. 2005;106:2269–2275
  2. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148:932–938
  3. Lemanek KL, Ranalli M. Sickle Cell Disease. In:  Roberts MC,  Steele RG editor. Handbook of pediatric psychology. 4th ed. New York & London: The Guilford Press; 2009;
  4. Barakat LP, Smith-Whitley K, Ohene-Frempong K. Treatment adherence in children with sickle cell disease: disease-related risk and psychosocial resistance factors. J Clin Psychol Med Settings. 2002;9:201–209
  5. Witherspoon D, Drotar D. Correlates of adherence to prophylactic penicillin therapy in children with sickle cell disease. Children's Health Care. 2006;35:281–296
  6. de Montalembert M, Brousse V, Elie C, Bernaudin F, Shi J, Landais P. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica. 2006;91:125–128
  7. Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr. 2010;156:415–419
  8. Pai ALH, Drotar D. Treatment adherence impact: the systematic assessment and quantification of the impact of treatment adherence on pediatric medical and psychological outcomes. J Pediatr Psychol. In press 2009.
  9. Bender BG, Bartlett SJ, Rand CS, Turner C, Wamboldt FS, Zhang L. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics. 2007;120:e471–e477
  10. Modi AC, Crosby LE, Guilfoyle SM, Lemanek KL, Witherspoon D, Mitchell MJ. Barriers to treatment adherence for pediatric patients with sickle cell disease and hteir families. Child Health Care. 2009;38:107–122
  11. Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33:590–611
  12. Pai ALH, Drotar D. Medication adherence in pediatric oncology. In:  Kazak AE,  Kupst MJ,  Pao M,  Patenaude AF,  Wiener L editor. Quick reference for oncology clinicians: the psychiatric and psychological dimensions of cancer symptom management. Charlottesville, VA: IPOS Press; 2009;p. 90–96

PII: S0022-3476(09)01080-4

doi: 10.1016/j.jpeds.2009.10.035

The Journal of Pediatrics
Volume 156, Issue 3 , Pages 350-351 , March 2010